This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Leif Pierre Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Al-Rashidi, F. Articles by Koul, B. Search for Related Content PubMed PubMed Citation Articles by Al-Rashidi, F. Articles by Koul, B. Related Collections Anesthesia Cardiac - other Extracorporeal circulation Valve disease Related Articles

Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation

Cardiothoracic Surgery, University Hospital Lund, 221 85 Lund, Sweden

*Corresponding author. Tel.: +46 703491649; fax: +46 46158635.

E-mail address: bansi.koul{at}skane.se (B. Koul).

The effect of acute intraoperative plateletpheresis (25% platelet yield) in combination with intraoperative low-dose aprotinin (2 million units) on blood conservation was investigated in 18 young adult patients undergoing elective Ross operation. The results were compared with a group of 19 similar patients without plateletpheresis (control group). The hematological and coagulation parameters at admission and discharge were statistically similar in both groups. The total blood product transfusion requirements were significantly reduced in the plateletpheresis group compared with the control group (3.2 units and 5.1 units, respectively, P=0.036). The total blood donor exposure was also reduced significantly in the plateletpheresis group compared with the control group (3.2 and 6.9 donors/patient, respectively, P<0.001). The direct costs for the hospital for the plateletpheresis procedure, including costs for all blood products, were similar to those for blood products alone in the control group. In summary, acute plateletpheresis in combination with low-dose aprotinin significantly reduces the blood product transfusions and blood donor exposures following the Ross operation; the treatment is cost-effective.

Key Words: Blood conservation; Platelets; Cardiopulmonary bypass; Ross operation

Related Articles

ICVTS on-line discussion A Plateletpheresis or aprotinin, which is the key element?

Chung-Dann Kan
Interactive CardioVascular and Thoracic Surgery 2007 6: 622. [Full Text] [PDF]

This article has been cited by other articles:

				C.-D. Kan ICVTS on-line discussion A Plateletpheresis or aprotinin, which is the key element? Interactive CardioVascular and Thoracic Surgery, October 1, 2007; 6(5): 622 - 622. [Full Text] [PDF]

				B. Koul, F. Al-Rashidi, M. Bhat, and L. Pierre ICVTS on-line discussion A1 Reply to Kan Interactive CardioVascular and Thoracic Surgery, October 1, 2007; 6(5): 622 - 622. [Full Text] [PDF]